Do Oncology Clinical Trial Participants Cost More for Payers?


The short answer is no. In this transcript and video, Davey Daniel, MD, hematology/medical oncology specialist, Tennessee Oncology, discusses findings of an abstract presented at ASCO 2021 showing a lower total cost of care paid by Medicare for episodes of care for patients in the Oncology Care Model (OCM) enrolled in clinical trials vs. those receiving routine care.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.